
Bonescreen is a Munich-based MedTech company founded in 2022, specializing in AI-driven assessment of spine health. Leveraging a deep interdisciplinary team with expertise in physics, computer science, medicine, and radiology, Bonescreen extracts non-invasive biomarkers from routine CT data to aid clinicians in bone health evaluations. Their core products are SpineQ®, a CE-marked medical device for osteoporosis diagnosis using existing CT scans, and SpineR, a research-oriented solution for automated spinal analysis, segmentation, and labeling for applications like surgical planning and finite element modeling. The company aims to improve the quality of diagnostics, enable opportunistic screening, and support preventative healthcare, particularly for osteoporosis, by making complex data understandable and actionable for medical professionals. Bonescreen's mission is to prevent bone fractures and promote healthy aging by focusing on early detection and prevention through data-driven insights.

Bonescreen is a Munich-based MedTech company founded in 2022, specializing in AI-driven assessment of spine health. Leveraging a deep interdisciplinary team with expertise in physics, computer science, medicine, and radiology, Bonescreen extracts non-invasive biomarkers from routine CT data to aid clinicians in bone health evaluations. Their core products are SpineQ®, a CE-marked medical device for osteoporosis diagnosis using existing CT scans, and SpineR, a research-oriented solution for automated spinal analysis, segmentation, and labeling for applications like surgical planning and finite element modeling. The company aims to improve the quality of diagnostics, enable opportunistic screening, and support preventative healthcare, particularly for osteoporosis, by making complex data understandable and actionable for medical professionals. Bonescreen's mission is to prevent bone fractures and promote healthy aging by focusing on early detection and prevention through data-driven insights.